Insulin administration may trigger type 1 diabetes in Japanese type 2 diabetes patients with type 1 diabetes high-risk HLA class II and the insulin gene VNTR genotype.

CONTEXT Insulin administration causes various types of immune responses to insulin. We previously reported three cases of type 1 diabetes mellitus (T1DM) triggered by insulin administration in Japanese type 2 diabetes mellitus patients. OBJECTIVE The objective of this study was to collect information and characterize insulin-triggered T1DM immunologically and genetically. METHODS Data for six patients (four men and two women) with insulin-triggered T1DM aged 59.5 ± 12.8 years were collected. Serum or urinary C-peptides, islet-related autoantibodies, insulin antibody, human leukocyte antigen, or the insulin gene variable number of tandem repeat genotype were analyzed. Th1- or Th2-associated responses were evaluated using an Enzyme-Linked ImmunoSpot assay. RESULTS None of the subjects had received insulin therapy or had an autoantibody to the 65-kDa isoform of glutamic acid decarboxylase before insulin administration. After insulin administration blood glucose control deteriorated acutely without any apparent cause, whereas C-peptide levels rapidly decreased to insulin-deficient levels. The mean duration of insulin administration to the development of T1DM was 7.7 ± 6.1 months. Islet-related autoantibodies became positive, whereas insulin allergy or a high titer of insulin antibody was observed in several cases. All had T1DM high-risk human leukocyte antigen class II (IDDM1) and the insulin gene variable number of tandem repeats genotype (IDDM2). GAD-reactive and insulin peptide-reactive Th1 cells, but not Th2 cells, were identified in two of four cases. CONCLUSIONS The findings suggest that insulin administration may have triggered TIDM in patients with type 2 diabetes mellitus. IDDM1 and IDDM 2 as well as autoreactive T cells may contribute to the development of T1DM. Developing insulin-triggered T1DM if a patient's blood glucose control acutely deteriorates after insulin administration should be carefully considered.

[1]  J. Todd,et al.  Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus , 1997, Nature Genetics.

[2]  E. Bonifacio,et al.  IDDM2/insulin VNTR modifies risk conferred by IDDM1/HLA for development of Type 1 diabetes and associated autoimmunity , 2003, Diabetologia.

[3]  S. Fineberg,et al.  Immunological responses to exogenous insulin. , 2007, Endocrine reviews.

[4]  L. Groop,et al.  Antibodies to Glutamic Acid Decarboxylase Reveal Latent Autoimmune Diabetes Mellitus in Adults With a Non—Insulin-Dependent Onset of Disease , 1993, Diabetes.

[5]  T. Kobayashi,et al.  Immunogenetic and Clinical Characterization of Slowly Progressive IDDM , 1993, Diabetes Care.

[6]  C. Polychronakos,et al.  The molecular genetics of type 1 diabetes: new genes and emerging mechanisms. , 2008, Trends in molecular medicine.

[7]  K. Tokunaga,et al.  Patients with Graves' disease who developed insulin autoimmune syndrome (Hirata disease) possess HLA-Bw62/Cw4/DR4 carrying DRB1*0406. , 1993, The Journal of clinical endocrinology and metabolism.

[8]  K. Eguchi,et al.  Type 1 diabetes in Japan , 2006, Diabetologia.

[9]  K. Hara,et al.  Immunological aspects of 'fulminant type 1 diabetes'. , 2007, Diabetes research and clinical practice.

[10]  I. Takei,et al.  Insulin intervention in slowly progressive insulin-dependent (type 1) diabetes mellitus. , 2008, The Journal of clinical endocrinology and metabolism.

[11]  S. Ito,et al.  Characteristics of the antibodies of two patients who developed daytime hyperglycemia and morning hypoglycemia because of insulin antibodies. , 2009, Diabetes research and clinical practice.

[12]  M. Peakman,et al.  Translational Mini‐Review Series on Type 1 Diabetes:
Systematic analysis of T cell epitopes in autoimmune diabetes , 2007, Clinical and experimental immunology.

[13]  Y. Ikeda,et al.  Type 1 diabetes developed in a type 2 diabetic patient with severe insulin resistance. , 2005, Diabetes research and clinical practice.

[14]  A. Imagawa,et al.  Insulin administration may trigger pancreatic beta-cell destruction in patients with type 2 diabetes. , 2008, Diabetes research and clinical practice.

[15]  Sato Takekawa,et al.  "Type 1 on type 2" diabetes mellitus: autoimmune type 1 diabetes superimposed on established type 2 diabetes. , 2007, Internal medicine.

[16]  Y. Matsuzawa,et al.  A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related antibodies. Osaka IDDM Study Group. , 2000, The New England journal of medicine.

[17]  M. Knip,et al.  Insulin Treatment in Patients With Type 1 Diabetes Induces Upregulation of Regulatory T-Cell Markers in Peripheral Blood Mononuclear Cells Stimulated With Insulin In Vitro , 2006, Diabetes.

[18]  A. M. Neale,et al.  Antigen-Based Vaccination and Prevention of Type 1 Diabetes , 2013, Current Diabetes Reports.

[19]  A. Imagawa,et al.  Fulminant type 1 diabetes: a nationwide survey in Japan. , 2003, Diabetes care.

[20]  C. Boitard,et al.  T Cell Recognition of Autoantigens in Human Type 1 Diabetes: Clinical Perspectives , 2011, Clinical & developmental immunology.

[21]  T. Maruyama,et al.  Insulin gene/IDDM2 locus in Japanese type 1 diabetes: contribution of class I alleles and influence of class I subdivision in susceptibility to type 1 diabetes. , 2007, The Journal of clinical endocrinology and metabolism.